Professional opportunities for toxicologists: The requirements of the private sector for education/teaching

Toxicology Letters

Volumn 112-113, Issue , 2000, Pages 371-378

  Ettlin, Robert A ^a   Hodel, Christian M ^b  

^a NOVARTIS PHARMA AG   (Switzerland)

^b HOVAT Pharma Consulting   (Switzerland)

Author keywords

Education; Industry; Toxicology

Indexed keywords

CAREER; CONFERENCE PAPER; DRUG INDUSTRY; ORGANIZATION AND MANAGEMENT; PRIORITY JOURNAL; RESEARCH; TOXICOLOGY; TRAINING;

CAREER MOBILITY; CHEMICAL INDUSTRY; DRUG INDUSTRY; HUMANS; JOB DESCRIPTION; PRIVATE SECTOR; TEACHING; TOXICOLOGY;

EID: 17144442974     PISSN: 03784274     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0378-4274(99)00257-X     Document Type: Conference Paper

References (34)

1. Alden C.L., Sagartz J.E., Smith P.F., Wilson A.G., Bunch R.T., Morris D.L. The pathologist and toxicologist in pharmaceutical product discovery. Toxicol. Pathol. 27:1999;104-106.
2. Andersen M.E. Development of physiologically based pharmacokinetic and physiologically based pharmacodynamic models for applications in toxicology and risk assessment. Toxicol. Lett. 79:1995;35-44.
3. Aldridge W.N., Schlatter Ch. Training and education in toxicology, a discussion. Arch. Toxicol. 45:1980;249-256.
4. Anonymous, 1978. Editorial. The education of a toxicologist. Toxicol. Appl. Pharmacol. 45, 375-376.
5. Anonymous, 1979. SOT works toward certification of toxicologists and facilities. Vet. Hum. Toxicol. 21, 169.
6. Bock K.-W., Greim H., Kappus H., Marquardt H., Neumann H.-G., Oesch F., Schulte-Hermann R. Zur situation der toxikologie in der Bundesrepublik Deutschland. DGPT Mitt. 9:1992;4-7.
7. Chang M.J.W. Recent situation and future perspectives of the certification of toxicologists. J. Toxicol. Sci. 23(Suppl. II):1998;273-274.
8. Corton J.C., Anderson S.P., Stauber A.J., Janszen D.B., Kimbell J.S., Conolly R.B. Entering the era of toxicogenomics with DNA microarrays. CIIT Acta. 19(2):1999;1-8.
9. Dorman D.C., Medinsky M.A., Griffin W. The CIIT education and training program. CIIT Acta. 12(8):1992;1-5.
10. Ettlin, R.A., 1992. Viewpoints on certification of toxicologists. In: R.A. Ettlin (Ed.), EUROTOX Newsletter 3 (9), 29-92.
11. Farlee C. Who is a toxicologist? Vet. Hum. Toxicol. 21:1979;183-188.
12. Fowler J., Jackson M., Boobis A. The 'Register of Toxicologists'. Hum. Exp. Toxicol. 13:1994;377-380.
13. Frohberg H. Nachwuchsförderung von Toxikologen - weiterbildung in der industrie. Pharm. Ind. 34(10):1972;739-742.
14. Geiling E.M.K., Cannon P.R. Pathological effects of elixir of sulfanilamide (diethylene glycol) poisoning. JAMA. 111:1938;919-926.
15. Gibson J.E. We must keep toxicologists current. Vet. Hum. Toxicol. 21:1979;180-182.
16. Hambleton P. Clostridium botulinum toxins: a general review of involvement in disease, structure, mode of action and preparation for clinical use. J. Neurol. 239:1992;16-20.
17. Hesse-Callaway S. What makes a toxicologist? Regul. Toxicol. Pharmacol. 24:1996;195-196.
18. Hesse-Callaway S., Greim H. The German toxicology curriculum: establishing a postgraduate training program for experts in toxicology. Regul. Toxicol. Pharmacol. 24:1996;197-201.
19. Lenz W., Knapp K. Die Thalidomid-Embroypathie. DMW. 87:1962;1232-1242.
20. Lumley C. Clinical toxicity: could it have been predicted? Pre-marketing experience. Lumley C.E., Walker S.R. Animal Toxicity Studies: their relevance for man. 1990;49-56 Quay Publishing, Lancaster.
21. MacGregor J.T., Farr S., Tucker J.D., Heddle J.A., Tice R.R., Turteltaub K.W. New molecular endpoints and methods for routine toxicity testing. Fundam. Appl. Toxicol. 26:1995;156-173.
22. McBride W.G. Thalidomide and congenital abnormalities. Lancet. 2:1961;1358.
23. Medinsky M.A., Griffin W. The education and training program at the Chemical Industry Institute of Toxicology. CIIT Acta. 10(9-10):1990;1-4.
24. Menzel D.B. Extrapolating the future: research trends in modeling. Toxicol. Lett. 79:1995;299-303.
25. Mertz C.K., Slovic P., Purchase I.F. Judgments of chemical risks: comparison among senior managers, toxicologists and the public. Risk Anal. 18:1998;391-404.
26. Miya T.S., Gibson J.E., Hook J.B., McClellan R.O. Preparing for the twenty-first century: report of the Tox-90's Commission. Toxicol. Appl. Pharmacol. 96:1988;1-6.
27. Neal R.A. A career in toxicology. Ann. Rev. Pharmacol. Toxicol. 36:1996;35-46.
28. Oehme, F.W., 1998. The recent situation and future perspectives of the certification of toxicologists. J. Toxicol. Sci. 23, Suppl. II, 275-277.
29. Parke D.V. The phoenix of modern toxicology. Fundam. Appl. Toxicol. 34:1996;1-4.
30. Prentice, D.E., 1990. Working group on postgraduate education in toxicology and toxicologic pathology. In: R.A. Ettlin (Ed.) EUROTOX Newsletter 2 (90), 25-26.
31. Savolainen K.M. Registration of toxicologists in Europe. J. Toxicol. Sci. 23(Suppl. II):1998;268-272.
32. Silverman L., Campbell R., Broach J.R. New assay technologies for high-throughput screening. Curr. Opin. Chem. Biol. 2:1998;397-403.
33. Tryphonas L., Schwartz L.W., Levin S., Haschek W.M. Toxicologic pathology: modern challenges and the need for a new educational strategy. Toxicol. Pathol. 22:1994;330-332.
34. Tsuda S. Recent situation and future perspectives of the certification of toxicologists in Japan. J. Toxicol. Sci. 23(Suppl. II):1998;278-279.